{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T16:01:31Z","timestamp":1790870491458,"version":"4.1.0"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100018956","name":"NIHR Cambridge Biomedical Research Centre","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100018956","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000272","name":"National Institute for Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000274","name":"British Heart Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000274","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cardiovascular Revascularization Medicine"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1016\/j.carrev.2021.10.006","type":"journal-article","created":{"date-parts":[[2021,10,15]],"date-time":"2021-10-15T05:57:12Z","timestamp":1634277432000},"page":"6-11","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Trans-Myocardial Blood Interleukin-6 Levels Relate to Intracoronary Imaging-Defined Features of Plaque Vulnerability and Predict Procedure-Induced Myocardial Infarction"],"prefix":"10.1016","volume":"39","author":[{"given":"Paul","family":"Bambrough","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Peverelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam J.","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joel P.","family":"Giblett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin R.","family":"Bennett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas E.J.","family":"West","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen P.","family":"Hoole","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.carrev.2021.10.006_bb0005","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1056\/NEJMoa1002358","article-title":"A prospective natural-history study of coronary atherosclerosis","volume":"364","author":"Stone","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.carrev.2021.10.006_bb0010","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1016\/j.ahj.2005.06.040","article-title":"Coronary plaque composition of nonculprit lesions, assessed by in vivo intracoronary ultrasound radio frequency data analysis, is related to clinical presentation","volume":"151","author":"Rodriguez-Granillo","year":"2006","journal-title":"Am Heart J"},{"key":"10.1016\/j.carrev.2021.10.006_bb0015","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1016\/j.jcmg.2011.05.005","article-title":"Association between IVUS findings and adverse outcomes in patients with coronary artery disease: the VIVA (VH-IVUS in Vulnerable Atherosclerosis) Study","volume":"4","author":"Calvert","year":"2011","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.carrev.2021.10.006_bb0020","doi-asserted-by":"crossref","first-page":"304","DOI":"10.21037\/cdt.2015.10.03","article-title":"Stabilization of high-risk plaques","volume":"6","author":"Takata","year":"2016","journal-title":"Cardiovasc Diagn Ther"},{"key":"10.1016\/j.carrev.2021.10.006_bb0025","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.1016\/j.jacc.2020.09.547","article-title":"Percutaneous coronary intervention for vulnerable coronary atherosclerotic plaque","volume":"76","author":"Stone","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.carrev.2021.10.006_bb0030","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1161\/CIRCRESAHA.118.313591","article-title":"Immunity and inflammation in atherosclerosis","volume":"124","author":"Wolf","year":"2019","journal-title":"Circ Res"},{"key":"10.1016\/j.carrev.2021.10.006_bb0035","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.ijcard.2010.09.059","article-title":"Inflammatory markers and plaque morphology: an optical coherence tomography study","volume":"154","author":"Bouki","year":"2012","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.carrev.2021.10.006_bb0040","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1056\/NEJMoa1707914","article-title":"Antiinflammatory therapy with Canakinumab for atherosclerotic disease","volume":"377","author":"Ridker","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.carrev.2021.10.006_bb0045","first-page":"6","article-title":"Inflammatory differences in plaque erosion and rupture in patients with ST-segment elevation myocardial infarction","author":"Chandran","year":"2017","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.carrev.2021.10.006_bb0050","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1160\/TH09-05-0297","article-title":"How much is too much? Interleukin-6 and its signalling in atherosclerosis","volume":"102","author":"Schuett","year":"2009","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.carrev.2021.10.006_bb0055","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1161\/01.CIR.101.12.1372","article-title":"Expression of angiotensin II and interleukin 6 in human coronary atherosclerotic plaques: potential implications for inflammation and plaque instability","volume":"101","author":"Schieffer","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.carrev.2021.10.006_bb0060","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1161\/ATVBAHA.111.229435","article-title":"Transsignaling of interleukin-6 crucially contributes to atherosclerosis in mice","volume":"32","author":"Schuett","year":"2012","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"Suppl. 2","key":"10.1016\/j.carrev.2021.10.006_bb0065","doi-asserted-by":"crossref","first-page":"S117","DOI":"10.1097\/00005344-199117002-00026","article-title":"Interleukin-6 stimulates proliferation of cultured vascular smooth muscle cells independently of interleukin-1 beta","volume":"17","author":"Morimoto","year":"1991","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1016\/j.carrev.2021.10.006_bb0070","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1038\/ni1406","article-title":"Fever-range thermal stress promotes lymphocyte trafficking across high endothelial venules via an interleukin 6 trans-signaling mechanism","volume":"7","author":"Chen","year":"2006","journal-title":"Nat Immunol"},{"key":"10.1016\/j.carrev.2021.10.006_bb0075","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.lfs.2005.04.052","article-title":"Resveratrol suppresses IL-6-induced ICAM-1 gene expression in endothelial cells: effects on the inhibition of STAT3 phosphorylation","volume":"78","author":"Wung","year":"2005","journal-title":"Life Sci"},{"key":"10.1016\/j.carrev.2021.10.006_bb0080","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.amjcard.2006.01.045","article-title":"Interleukin-6 and the risk of future cardiovascular events in patients with angina pectoris and\/or healed myocardial infarction","volume":"98","author":"Fisman","year":"2006","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.carrev.2021.10.006_bb0085","doi-asserted-by":"crossref","first-page":"e005077","DOI":"10.1161\/JAHA.116.005077","article-title":"Inflammatory biomarkers Interleukin-6 and C-reactive protein and outcomes in stable coronary heart disease: experiences from the STABILITY (stabilization of atherosclerotic plaque by initiation of darapladib therapy)","volume":"6","author":"Held","year":"2017","journal-title":"Trial J Am Heart Assoc"},{"key":"10.1016\/j.carrev.2021.10.006_bb0090","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1161\/01.CIR.103.7.947","article-title":"Cardiovascular disease, interleukin-6, and risk of mortality in older women: the women\u2019s health and aging study","volume":"103","author":"Volpato","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.carrev.2021.10.006_bb0095","doi-asserted-by":"crossref","first-page":"39","DOI":"10.5551\/jat.34884","article-title":"Patients with an inflamed atherosclerotic plaque have increased levels of circulating inflammatory markers","volume":"24","author":"Poredos","year":"2017","journal-title":"J Atheroscler Thromb"},{"key":"10.1016\/j.carrev.2021.10.006_bb0100","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1097\/MCA.0000000000000582","article-title":"Prediction of postpercutaneous coronary intervention myocardial infarction: insights from intravascular imaging, coronary flow, and biomarker evaluation","volume":"29","author":"Hoole","year":"2018","journal-title":"Coron Artery Dis"},{"key":"10.1016\/j.carrev.2021.10.006_bb0105","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1016\/j.jcmg.2015.06.014","article-title":"Predictors of plaque rupture within nonculprit fibroatheromas in patients with acute coronary syndromes: the PROSPECT study","volume":"8","author":"Zheng","year":"2015","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.carrev.2021.10.006_bb0110","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1016\/j.jacc.2018.08.1038","article-title":"Fourth universal definition of myocardial infarction (2018)","volume":"72","author":"Thygesen","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.carrev.2021.10.006_bb0115","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1536\/ihj.14-005","article-title":"Impact of coronary plaque burden and composition on periprocedural myocardial infarction and coronary flow reserve after percutaneous coronary intervention","volume":"55","author":"Higuchi","year":"2014","journal-title":"Int Heart J"},{"key":"10.1016\/j.carrev.2021.10.006_bb0120","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1161\/CIRCINTERVENTIONS.110.959080","article-title":"Periprocedural myocardial infarction: prevalence, prognosis, and prevention","volume":"3","author":"Lansky","year":"2010","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.carrev.2021.10.006_bb0125","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1161\/CIRCRESAHA.115.306656","article-title":"From C-reactive protein to Interleukin-6 to Interleukin-1: moving upstream to identify novel targets for Atheroprotection","volume":"118","author":"Ridker","year":"2016","journal-title":"Circ Res"},{"key":"10.1016\/j.carrev.2021.10.006_bb0130","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1016\/S0140-6736(11)61931-4","article-title":"Interleukin-6 receptor pathways in coronary heart disease: a collaborative meta-analysis of 82 studies","volume":"379","author":"Sarwar","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.carrev.2021.10.006_bb0135","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1016\/S0140-6736(12)60110-X","article-title":"The interleukin-6 receptor as a target for prevention of coronary heart disease: a mendelian randomisation analysis","volume":"379","author":"Interleukin-6 Receptor Mendelian Randomisation Analysis (IL6R MR) Consortium","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.carrev.2021.10.006_bb0140","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.1056\/NEJMoa1912388","article-title":"Efficacy and safety of low-dose colchicine after myocardial infarction","volume":"381","author":"Tardif","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.carrev.2021.10.006_bb0145","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0167-5273(02)00156-0","article-title":"Transcardiac gradient of soluble adhesion molecules predicts progression of coronary artery disease","volume":"84","author":"Yamamoto","year":"2002","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.carrev.2021.10.006_bb0150","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/S0002-9149(00)01121-8","article-title":"Sites of interleukin-6 release in patients with acute coronary syndromes and in patients with congestive heart failure","volume":"86","author":"Deliargyris","year":"2000","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.carrev.2021.10.006_bb0155","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.atherosclerosis.2009.03.033","article-title":"Coronary sinus concentrations of interleukin 6 and its soluble receptors are affected by reperfusion and may portend complications in patients with myocardial infarction","volume":"206","author":"Kaminski","year":"2009","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.carrev.2021.10.006_bb0160","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.cyto.2010.01.007","article-title":"Circadian variations of interleukin 6 in coronary circulations of patients with myocardial infarction","volume":"50","author":"Bonda","year":"2010","journal-title":"Cytokine"},{"key":"10.1016\/j.carrev.2021.10.006_bb0165","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1016\/j.amjcard.2007.03.105","article-title":"Meta-analysis of published reports on the effect of statin treatment before percutaneous coronary intervention on periprocedural myonecrosis","volume":"100","author":"Merla","year":"2007","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.carrev.2021.10.006_bb0170","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1016\/j.jacc.2013.08.720","article-title":"Consideration of a new definition of clinically relevant myocardial infarction after coronary revascularization: an expert consensus document from the Society for Cardiovascular Angiography and Interventions (SCAI)","volume":"62","author":"Moussa","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.carrev.2021.10.006_bb0175","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.ijcard.2006.07.112","article-title":"Relation between transcardiac gradient of VEGF and coronary flow response in humans","volume":"119","author":"Mende","year":"2007","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.carrev.2021.10.006_bb0180","doi-asserted-by":"crossref","first-page":"557","DOI":"10.5551\/jat.32300","article-title":"Myocardial production of plasminogen activator Inhibitor-1 is associated with coronary endothelial and ventricular dysfunction after acute myocardial infarction","volume":"23","author":"Shimizu","year":"2016","journal-title":"J Atheroscler Thromb"},{"key":"10.1016\/j.carrev.2021.10.006_bb0185","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.jacbts.2017.07.007","article-title":"Percutaneous sampling of local biomolecule gradients across coronary artery atherosclerotic plaques","volume":"2","author":"West","year":"2017","journal-title":"JACC Basic Transl Sci"},{"key":"10.1016\/j.carrev.2021.10.006_bb0190","series-title":"2008 computers in cardiology","first-page":"545","article-title":"Evidences of possible necrotic-core artifact around dense calcium in virtual histology images","author":"Sales","year":"2008"}],"container-title":["Cardiovascular Revascularization Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1553838921006825?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1553838921006825?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T10:23:09Z","timestamp":1761560589000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1553838921006825"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6]]},"references-count":38,"alternative-id":["S1553838921006825"],"URL":"https:\/\/doi.org\/10.1016\/j.carrev.2021.10.006","relation":{},"ISSN":["1553-8389"],"issn-type":[{"value":"1553-8389","type":"print"}],"subject":[],"published":{"date-parts":[[2022,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Trans-Myocardial Blood Interleukin-6 Levels Relate to Intracoronary Imaging-Defined Features of Plaque Vulnerability and Predict Procedure-Induced Myocardial Infarction","name":"articletitle","label":"Article Title"},{"value":"Cardiovascular Revascularization Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.carrev.2021.10.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}